Connect with us
Better works with healthcare professionals to determine which type of medications are best for patients, after having analyzed and parameterized their data. The company's platform, Better Meds, provides...
This year, the group plans to start marketing in Europe and sell 20,000 units of its devices, which will increase to 50,000 units in 2024. After...
To date, Ephion has agreements with five hospitals for the implementation of its Ephion Mobility technology in neuromuscular diseases: the Sant Joan de Deu Hospital, the...
Docline maintains an agreement with Mapfre, with whom it offers digital health programs to the company's policyholders; with the Ballesol retirement home company, to whose patients it...
Sicit specializes in the transformation of leather by-products into biostimulants for agriculture and retardants for the gypsum industry. The company offers a strategically important service for...
Looking ahead to 2024, the group plans to reach break-even, when the European Medicines Agency approves its drug against glioblastoma, an aggressive type of cancer that...
The company, which has 37 people on its staff, generates 80% of its turnover in the Spanish market and the remaining 20% in various international markets, including...
In November, Miwendo developed a first clinical study, and will now work on a second, both at the Hospital Clínic in Barcelona. The device, which the...
Qubiotech uses Artificial Intelligence-based image processing to develop diagnostics for brain diseases, which it has called Neurocloud. The software hosts three medical image quantification algorithms (PET,...
The Catalan pharmaceutical company Almirall earned €4.3 million in 2022 and surpassed the losses of €40.9 million it had in 2021. The normalized net result, which...
 |
|
 |  |
 |
|